{"id":375888,"date":"2024-02-29T10:04:51","date_gmt":"2024-02-29T09:04:51","guid":{"rendered":"https:\/\/medizinonline.com\/?p=375888"},"modified":"2024-02-29T10:19:45","modified_gmt":"2024-02-29T09:19:45","slug":"un-traitement-efficace-grace-a-limmunotherapie","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/un-traitement-efficace-grace-a-limmunotherapie\/","title":{"rendered":"Un traitement efficace gr\u00e2ce \u00e0 l\u2019immunoth\u00e9rapie"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Dans le traitement du carcinome \u00e0 cellules de Merkel m\u00e9tastatique (CCMm), la chimioth\u00e9rapie (CT) a toujours \u00e9t\u00e9 consid\u00e9r\u00e9e comme la norme, mais les taux de r\u00e9ponse ne persistent souvent pas au fil du temps&nbsp;[1, 2].&nbsp; Av\u00e9lumab est la premi\u00e8re et la seule immunoth\u00e9rapie anti-PD-L1 \u00e0 \u00eatre autoris\u00e9e en Suisse pour les patientes et patients atteints de CCMm et convainc aussi bien en premi\u00e8re&nbsp;ligne (1L) de traitement que lors des lignes suivantes (2L+), avec une r\u00e9ponse persistante et un avantage important en termes de survie pour les personnes concern\u00e9es&nbsp;[2-7]. Des donn\u00e9es r\u00e9centes confirment en outre son efficacit\u00e9 dans les conditions cliniques de la vie r\u00e9elle&nbsp;[8-10].<\/strong><\/p>\n\n\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fun-traitement-efficace-grace-a-limmunotherapie%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Dans le traitement du carcinome \u00e0 cellules de Merkel m\u00e9tastatique (CCMm), la chimioth\u00e9rapie (CT) a toujours \u00e9t\u00e9 consid\u00e9r\u00e9e comme la norme, mais les taux de r\u00e9ponse ne persistent souvent pas&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fun-traitement-efficace-grace-a-limmunotherapie%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":14,"featured_media":375858,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"0","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Sponsored Content: Carcinome \u00e0 cellules de Merkel m\u00e9tastatique","footnotes":""},"category":[11549,11345,11389,11535,11549],"tags":[40920,36081],"powerkit_post_featured":[],"class_list":["post-375888","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-contenu-des-partenaires","category-oncologie","category-rapports-de-congres","tag-congres","tag-oncologie","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-04 00:54:09","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":375895,"slug":"trattamento-di-successo-con-limmunoterapia","post_title":"Trattamento di successo con l'immunoterapia","href":"https:\/\/medizinonline.com\/it\/trattamento-di-successo-con-limmunoterapia\/"},"pt_PT":{"locale":"pt_PT","id":375892,"slug":"tratamento-bem-sucedido-com-imunoterapia","post_title":"Tratamento bem sucedido com imunoterapia","href":"https:\/\/medizinonline.com\/pt-pt\/tratamento-bem-sucedido-com-imunoterapia\/"},"es_ES":{"locale":"es_ES","id":375894,"slug":"exito-del-tratamiento-con-inmunoterapia","post_title":"\u00c9xito del tratamiento con inmunoterapia","href":"https:\/\/medizinonline.com\/es\/exito-del-tratamiento-con-inmunoterapia\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/375888","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=375888"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/375888\/revisions"}],"predecessor-version":[{"id":375911,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/375888\/revisions\/375911"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/375858"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=375888"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=375888"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=375888"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=375888"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}